Inhibition of cyclin-dependent kinases by purine analogues Crystal structure of human cdk2 complexed with roscovitine Walter Filgueira DE AZEVEDO,Sophie LECLERC,et al. Eur. J. Biochem 1997;243:518-526
Roscovitine, a novel cyclin-dependent kinase inhibitor, characterizes restriction point and G2/M transition in tobacco BY-2 cell suspension S6verine Planchais,Nathalie Glab,et al. The Plant Journal 1997;12(1), 191-202
Roscovitine inhibits the proliferative activity of immortal and neoplastic human breast epithelial cells. Mgbonyebi OP, Russo J, Russo IH. Anticancer Res. 1998 Mar-Apr;18(2A):751-5.
The pharmacological and toxicological properties of this product have not been fully investigated. Exercise caution in use and handling. This product must not be used in humans.